8-K
filed October 4, 2023, 7:59 PM ET
ticker SYRA
CIK 0001922335
other material
confidence high
sentiment neutral
materiality 0.75
Syra Health prices upsized IPO of 1.615M units at $4.125/unit, raises ~$6.7M gross
Syra Health Corp
- IPO units priced at $4.125 each: one share Class A common + one warrant (exercise $6.50, 5-year term).
- Gross proceeds of approx. $6.7 million before underwriting discounts and expenses.
- Shares began trading on Nasdaq on Sept 29 under ticker SYRA; IPO closed Oct 3, 2023.
- Underwriters partially exercised over-allotment for 242,250 warrants at $0.01 each; option remains for 242,250 additional shares.
- Five new independent directors appointed effective Oct 3: Rogers, Dahlem, V. Reddy, Paranjape, A. Reddy; committee chairs named.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Andrew Dahlem was appointed as Director at Syra Health Corp.
- Action
- appointed
- Role
- Director
Exact text from the filing
Effective as of October 3, 2023, each of Sherron Rogers, Andrew Dahlem, Vijayapal Reddy, Ketan Paranjape, and Avutu Reddy were appointed to serve as members of Syra Health Corp.'s (the “Company’s”) board of directors (the “Board”).
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Vijayapal Reddy was appointed as Director at Syra Health Corp.
- Action
- appointed
- Role
- Director
Exact text from the filing
Effective as of October 3, 2023, each of Sherron Rogers, Andrew Dahlem, Vijayapal Reddy, Ketan Paranjape, and Avutu Reddy were appointed to serve as members of Syra Health Corp.'s (the “Company’s”) board of directors (the “Board”).
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Avutu Reddy was appointed as Director at Syra Health Corp.
- Action
- appointed
- Role
- Director
Exact text from the filing
Effective as of October 3, 2023, each of Sherron Rogers, Andrew Dahlem, Vijayapal Reddy, Ketan Paranjape, and Avutu Reddy were appointed to serve as members of Syra Health Corp.'s (the “Company’s”) board of directors (the “Board”).
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Sherron Rogers was appointed as Director at Syra Health Corp.
- Action
- appointed
- Role
- Director
Exact text from the filing
Effective as of October 3, 2023, each of Sherron Rogers, Andrew Dahlem, Vijayapal Reddy, Ketan Paranjape, and Avutu Reddy were appointed to serve as members of Syra Health Corp.'s (the “Company’s”) board of directors (the “Board”).
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Ketan Paranjape was appointed as Director at Syra Health Corp.
- Action
- appointed
- Role
- Director
Exact text from the filing
Effective as of October 3, 2023, each of Sherron Rogers, Andrew Dahlem, Vijayapal Reddy, Ketan Paranjape, and Avutu Reddy were appointed to serve as members of Syra Health Corp.'s (the “Company’s”) board of directors (the “Board”).
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.